Iradimed Co Cash Flow-to-Debt Ratio
Iradimed Co cash flow-to-debt ratio. Iradimed Co (IRMD) has a Cash Flow-to-Debt Ratio of 0.45x as of June 2026, meaning its operating cash flow of $5.94 Million could theoretically repay 0% of its total liabilities ($13.23 Million) in one year. Check Iradimed Co cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Iradimed Co (2012–2025)
Cash flow-to-debt ratio of Iradimed Co from 2012 to 2025. Historical debt coverage capacity for Iradimed Co across 14 annual periods. Check how aggressively does Iradimed Co reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Iradimed Co Cash Flow-to-Debt Ratio by Year (2012–2025)
Iradimed Co cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Iradimed Co. For the full cash flow conversion analysis, see IRMD cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.76x | $24.95 Million | $14.16 Million | ▼ -20.9% |
| 2024 | 2.23x | $25.62 Million | $11.51 Million | ▲ +242.9% |
| 2023 | 0.65x | $13.47 Million | $20.74 Million | ▼ -23.4% |
| 2022 | 0.85x | $10.04 Million | $11.84 Million | ▼ -19.3% |
| 2021 | 1.05x | $11.26 Million | $10.71 Million | ▲ +75.0% |
| 2020 | 0.60x | $5.82 Million | $9.68 Million | ▼ -34.2% |
| 2019 | 0.91x | $10.23 Million | $11.20 Million | ▼ -19.6% |
| 2018 | 1.14x | $7.38 Million | $6.50 Million | ▲ +102.1% |
| 2017 | 0.56x | $3.42 Million | $6.08 Million | ▼ -68.3% |
| 2016 | 1.77x | $9.41 Million | $5.31 Million | ▼ -23.3% |
| 2015 | 2.31x | $7.65 Million | $3.31 Million | ▲ +116.1% |
| 2014 | 1.07x | $2.59 Million | $2.42 Million | ▲ +13.4% |
| 2013 | 0.94x | $1.47 Million | $1.56 Million | ▲ +45.8% |
| 2012 | 0.65x | $1.51 Million | $2.33 Million | — |